Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward : A Secondary Analysis
Recent studies suggest that COVID-19 survivors may experience long-term health consequences: in particular, neurological and mental health symptoms might be associated with long-term negative outcomes. This study is a secondary analysis of a larger cohort study and aims to determine the extent to which neurological and mental health sequelae are associated with survivors' disability. Participants include COVID-19 survivors, with no pre-morbid brain conditions, who were discharged from the COVID-19 Unit of the ASST Spedali Civili Hospital between February and April 2020. At an average of 3.5 months after discharge, they were submitted to a neurological examination and completed the WHO Disability Assessment Schedule (WHODAS-12), the Hospital Anxiety and Depression Score, the Pittsburgh Sleep Quality Index and the Montreal Cognitive Assessment. Multivariable regression analysis was carried out to analyze variables that explain WHODAS-12 variation. In total, 83 patients (63 males, average age 66.9, 95% CI: 64.2-69.7) were enrolled; average WHODAS-12 was 13.2 (95% CI: 9.7-16.6). Cognitive dysfunction, anxiety, fatigue, and hyposmia/hypogeusia explained 28.8% of WHODAS-12 variation. These findings underline the importance and need for longitudinal follow-up assessments after recovery from COVID-19 and suggest the need for early rehabilitation of residual symptoms to enhance patients' functioning.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
International journal of environmental research and public health - 19(2022), 7 vom: 02. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cacciatore, Martina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anxiety |
|---|
| Anmerkungen: |
Date Completed 13.04.2022 Date Revised 09.05.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijerph19074242 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339395303 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339395303 | ||
| 003 | DE-627 | ||
| 005 | 20231226002812.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijerph19074242 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1131.xml |
| 035 | |a (DE-627)NLM339395303 | ||
| 035 | |a (NLM)35409924 | ||
| 035 | |a (PII)4242 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cacciatore, Martina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward |b A Secondary Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.04.2022 | ||
| 500 | |a Date Revised 09.05.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Recent studies suggest that COVID-19 survivors may experience long-term health consequences: in particular, neurological and mental health symptoms might be associated with long-term negative outcomes. This study is a secondary analysis of a larger cohort study and aims to determine the extent to which neurological and mental health sequelae are associated with survivors' disability. Participants include COVID-19 survivors, with no pre-morbid brain conditions, who were discharged from the COVID-19 Unit of the ASST Spedali Civili Hospital between February and April 2020. At an average of 3.5 months after discharge, they were submitted to a neurological examination and completed the WHO Disability Assessment Schedule (WHODAS-12), the Hospital Anxiety and Depression Score, the Pittsburgh Sleep Quality Index and the Montreal Cognitive Assessment. Multivariable regression analysis was carried out to analyze variables that explain WHODAS-12 variation. In total, 83 patients (63 males, average age 66.9, 95% CI: 64.2-69.7) were enrolled; average WHODAS-12 was 13.2 (95% CI: 9.7-16.6). Cognitive dysfunction, anxiety, fatigue, and hyposmia/hypogeusia explained 28.8% of WHODAS-12 variation. These findings underline the importance and need for longitudinal follow-up assessments after recovery from COVID-19 and suggest the need for early rehabilitation of residual symptoms to enhance patients' functioning | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a WHODAS-12 | |
| 650 | 4 | |a anxiety | |
| 650 | 4 | |a brain impairment | |
| 650 | 4 | |a cognitive dysfunction | |
| 650 | 4 | |a disability | |
| 650 | 4 | |a fatigue | |
| 650 | 4 | |a hypogeusia | |
| 650 | 4 | |a hyposmia | |
| 700 | 1 | |a Raggi, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Pilotto, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Cristillo, Viviana |e verfasserin |4 aut | |
| 700 | 1 | |a Guastafierro, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Toppo, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Magnani, Francesca G |e verfasserin |4 aut | |
| 700 | 1 | |a Sattin, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Mariniello, Arianna |e verfasserin |4 aut | |
| 700 | 1 | |a Silvaggi, Fabiola |e verfasserin |4 aut | |
| 700 | 1 | |a Cotti Piccinelli, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Zoppi, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Bonzi, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Gipponi, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Libri, Ilenia |e verfasserin |4 aut | |
| 700 | 1 | |a Bezzi, Michela |e verfasserin |4 aut | |
| 700 | 1 | |a Martelletti, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Leonardi, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Padovani, Alessandro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of environmental research and public health |d 2004 |g 19(2022), 7 vom: 02. Apr. |w (DE-627)NLM162777434 |x 1660-4601 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2022 |g number:7 |g day:02 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijerph19074242 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2022 |e 7 |b 02 |c 04 | ||